• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高剂量放射性碘治疗在全甲状腺切除术后残余组织清除中的有效性]

[Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].

作者信息

Schümichen C, Bulczak-Schmidt M, Blattmann H, Pauli-Harnasch C

出版信息

Nuklearmedizin. 1984 Oct;23(5):265-9.

PMID:6522276
Abstract

The efficacy of high doses of radioiodine for total ablation of functional remnants left behind after total surgical thyroidectomy for thyroid cancer decreases with the number of treatments as well with the course of therapy. Most effective are 500 mCi of 131I administered in 5 fractions within 3 years. Up to 1000 mCi of 131I delivered within 5 years are still powerful but much less so. All further treatments with high doses of radioiodine are only of diagnostic value for detection of functional metastases with low radioiodine uptake. In about 45% of all patients even excessively high doses of radioiodine failed to ablate all functional residual thyroid tissue.

摘要

高剂量放射性碘对甲状腺癌全甲状腺切除术后残留功能组织进行完全消融的疗效,会随着治疗次数以及治疗疗程而降低。最有效的是在3年内分5次给予500毫居里的131I。在5年内给予高达1000毫居里的131I仍然有效,但效果要差得多。所有进一步使用高剂量放射性碘的治疗仅对检测低放射性碘摄取的功能性转移灶具有诊断价值。在所有患者中,约45%的患者即使使用过高剂量的放射性碘也未能消融所有功能性残留甲状腺组织。

相似文献

1
[Effectiveness of high-dosage radioiodine therapy in the elimination of remnant tissue following total thyroidectomy].[高剂量放射性碘治疗在全甲状腺切除术后残余组织清除中的有效性]
Nuklearmedizin. 1984 Oct;23(5):265-9.
2
A prospective clinical trial to assess the efficacy of radioiodine ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer undergoing sub-total thyroidectomy.一项前瞻性临床试验,旨在评估放射性碘消融作为接受甲状腺次全切除术的分化型甲状腺癌患者甲状腺全切术替代方案的疗效。
Acta Oncol. 2006;45(8):1067-72. doi: 10.1080/02841860500418377.
3
Cumulative doses of adjunct 131I treatment depend on location of residual thyroid tissue after total thyroidectomy in differentiated thyroid cancer.分化型甲状腺癌全甲状腺切除术后辅助性¹³¹I治疗的累积剂量取决于残余甲状腺组织的位置。
J Pediatr Surg. 2007 May;42(5):853-6. doi: 10.1016/j.jpedsurg.2006.12.039.
4
Assessment of the efficacy of iodine-131 for thyroid ablation.碘-131用于甲状腺消融的疗效评估。
J Nucl Med. 1993 Nov;34(11):1927-30.
5
An analysis of "ablation of thyroid remnants" with I-131 in 511 patients from 1947-1984: experience at University of Michigan.1947年至1984年间对密歇根大学511例患者进行的I-131“甲状腺残余组织消融”分析:经验总结
J Nucl Med. 1984 Dec;25(12):1287-93.
6
Treatment for microcarcinoma of the thyroid--clinical experience.甲状腺微小癌的治疗——临床经验
Clin Nucl Med. 2007 Apr;32(4):279-81. doi: 10.1097/01.rlu.0000257272.90126.3d.
7
Role of radioiodine in management of thyroid cancer: experience with 70 cases.放射性碘在甲状腺癌治疗中的作用:70例病例经验
Bangladesh Med Res Counc Bull. 1992 Dec;18(2):68-71.
8
[Effect of the plan of therapy on prognosis in thyroid cancer].
Nuklearmedizin. 1983 Apr;22(2):97-105.
9
Fractionated doses of radioiodine for ablation of postsurgical thyroid tissue remnants.用于消融术后甲状腺组织残余的分次放射性碘剂量。
Clin Nucl Med. 1990 Oct;15(10):676-7.
10
Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients.131碘治疗分化型甲状腺癌——一种定量放射剂量学方法:85例患者的结果与验证
J Nucl Med. 1992 Jun;33(6):1132-6.